首页> 外国专利> POWDERED MEDICAMENT FOR NASAL DELIVERY OF ASCORBIC ACID FOR REDUCING APOMORPHINE INDUCED TOXICITY TO CILIATED TISSUE

POWDERED MEDICAMENT FOR NASAL DELIVERY OF ASCORBIC ACID FOR REDUCING APOMORPHINE INDUCED TOXICITY TO CILIATED TISSUE

机译:鼻酸抗坏血酸粉剂用于减轻阿扑吗啡对纤毛的毒性

摘要

Use of ascorbic acid in the manufacture of a powdered medicament for nasal delivery, said medicament comprising an active agent that exhibits toxicity to ciliated tissue wherein the active agent is apomorphine, optionally in the form of a pharmaceutically acceptable salt or hydrate, for ameliorating said toxicity.
机译:抗坏血酸在制备用于鼻腔输送的粉状药物中的用途,所述药物包含对纤毛组织表现出毒性的活性剂,其中所述活性剂为阿扑吗啡,任选地为药学上可接受的盐或水合物形式,以减轻所述毒性。

著录项

  • 公开/公告号NZ583767A

    专利类型

  • 公开/公告日2012-06-29

    原文格式PDF

  • 申请/专利权人 BRITANNIA PHARMACEUTICALS LIMITED;

    申请/专利号NZ20080583767

  • 发明设计人 LAMBERT PETER;MERKUS FRANCISCUS W;

    申请日2008-08-04

  • 分类号A61K31/375;A61K9/14;A61K31/473;A61P43;

  • 国家 NZ

  • 入库时间 2022-08-21 17:23:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号